If you have a diagnosed metabolic condition, are on medication, or have specific dietary restrictions, it's worth speaking to your GP or a dietitian before making significant changes
Watch the Pancreas: Alcohol use is a leading cause of pancreatitis
GLP-1 therapies like Semaglutide and Tirzepatide are changing what we thought medicines could do
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), such as semaglutide (marketed as Ozempic and Wegovy), have gained widespread attention for their effectiveness in treating type 2 diabetes and aiding in weight loss
In tumor-bearing mice, capmatinib was able to inhibit tumor growth and even cause complete regression of some tumor lines without any noticeable toxicity
The report indicated that glucagon-like peptide-2 receptor (GLP-2R) agonists like teduglutide ([Gly2]GLP-2) have retention in patients with renal disease